| Health / Medical Topics |
IGF Ligand Neutralizing Antibody BI 836845
A humanized IgG1 insulin-like growth factor (IGF) monoclonal antibody targeting the IGF ligands 1 (IGF-1) and 2 (IGF-2), with potential antineoplastic activity. Upon administration, IGF ligand neutralizing antibody BI 836845 binds to both IGF-1 and IGF-2 and inhibits the binding of these ligands to their receptor, IGF-1R. This blocks the insulin growth factor (IGF) signaling pathway, which is upregulated in a number of cancer cell types and plays a key role in cancer cell proliferation and chemoresistance. In addition, BI 836845 prevents the binding of IGF-2 to insulin receptor variant A (IR-A), preventing its activation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A protein made by the body that stimulates the growth of many types of cells. IGF is similar to insulin (a hormone…
An immunoglobulin isotype (subclass). This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast…
An immunoglobulin isotype (subclass). This isotype is expressed on naive B cells along with IgM. Little is known about its…
Human IGBP1 wild-type allele is located within Xq13.1-q13.3 and is approximately 33 kb in length. This allele, which encodes immunoglobulin-binding protein 1,…
This gene is involved in multiple signal transduction pathways.
A chronic autoimmune glomerulonephritis characterized by the deposition of immunoglobulin A in the mesangium of the glomeruli. It is manifested with hematuria…
